JoVE Logo
Faculty Resource Center

Sign In

Abstract

Immunology and Infection

Aktivering og konjugering av løselige polysakkarider med 1-cyano-4-dimetylaminopyridin tetrafluoroborate (CDAP)

Published: June 14th, 2021

DOI:

10.3791/62597

1Fina Biosolutions LLC

ERRATUM NOTICE

Important: There has been an erratum issued for this article. Read more …

Konjugatvaksiner er bemerkelsesverdige fremskritt innen vaksinering. For fremstilling av polysakkaridkonjugatvaksiner kan polysakkaridene enkelt funksjonaliseres og knyttes til vaksinebærerproteiner ved hjelp av 1-cyano-4-dimetylaminopyridintetrafluoroborate (CDAP), et cyanylerende reagens som er lett å håndtere. CDAP aktiverer polysakkarider ved å reagere med karbohydrathydroksylgrupper ved pH 7-9. Stabiliteten og reaktiviteten til CDAP er svært pH-avhengig. pH-en til reaksjonen reduseres også under aktivering på grunn av hydrolysen til CDAP, noe som gjør at god pH kontrollerer nøkkelen til reproduserbar aktivering. Den opprinnelige CDAP-aktiveringsprotokollen ble utført ved romtemperatur i ubuffered pH 9-løsninger.

På grunn av den raske reaksjonen under denne tilstanden (<3 min) og det medfølgende raske pH-fallet fra den raske CDAP-hydrolysen, var det utfordrende å raskt justere og opprettholde målreaksjonen pH på kort tid. Den forbedrede protokollen som er beskrevet her, utføres ved 0 °C, noe som bremser CDAP-hydrolysen og forlenger aktiveringstiden fra 3 min til ~15 min. Dimetylaminopyridin (DMAP) ble også brukt som en buffer for å forhåndsjustere polysakkaridløsningen til målaktiverings-pH før du legger til CDAP-reagenset. Den lengre reaksjonstiden, kombinert med den langsommere CDAP-hydrolysen og bruken av DMAP-buffer, gjør det enklere å opprettholde aktiverings-pH for hele aktiveringsprosessens varighet. Den forbedrede protokollen gjør aktiveringsprosessen mindre frenetisk, mer reproduserbar og mer egnet til å skalere opp.

Erratum

Erratum: Activation and Conjugation of Soluble Polysaccharides using 1-Cyano-4-Dimethylaminopyridine Tetrafluoroborate (CDAP)

An erratum was issued for: Activation and Conjugation of Soluble Polysaccharides using 1-Cyano-4-Dimethylaminopyridine Tetrafluoroborate (CDAP). A figure was updated.

Figure 4 was updated from:

Figure 4
Figure 4: Representative results for CDAP activation of dextran. Typical standard curves for the (A) resorcinol/sulfuric acid and (B) TNBS assays. The assay results for dextran activated with 0.25 and 0.5 mg CDAP/mg dextran are shown. Glucose was used as the standard for the resorcinol assay. Dextran, in mg/mL, is divided by 100 kDa to give a molar concentration. The hydrazide concentration is determined using ADH as the standard and the results expressed as µM Hz. (C) Calculation of hydrazide: dextran ratios.The level of derivatization was calculated as hydrazides per 100 kDa of dextran to facilitate the comparison between polymers of different average molecular weights. The % weight ratio of g ADH/g dextran was calculated using a MW of 174 g/mole for ADH. Please click here to view a larger version of this figure.

to:

Figure 4
Figure 4: Representative results for CDAP activation of dextran. Typical standard curves for the (A) resorcinol/sulfuric acid and (B) TNBS assays. The assay results for dextran activated with 0.25 and 0.5 mg CDAP/mg dextran are shown. Glucose was used as the standard for the resorcinol assay. Dextran, in mg/mL, is divided by 100 kDa to give a molar concentration. The hydrazide concentration is determined using ADH as the standard and the results expressed as µM Hz. (C) Calculation of hydrazide: dextran ratios.The level of derivatization was calculated as hydrazides per 100 kDa of dextran to facilitate the comparison between polymers of different average molecular weights. The % weight ratio of g ADH/g dextran was calculated using a MW of 174 g/mole for ADH. Please click here to view a larger version of this figure.

Tags

Immunologi og infeksjon

This article has been published

Video Coming Soon

JoVE Logo

Privacy

Terms of Use

Policies

Research

Education

ABOUT JoVE

Copyright © 2024 MyJoVE Corporation. All rights reserved